Anna Tassidou

653 total citations
13 papers, 482 citations indexed

About

Anna Tassidou is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Anna Tassidou has authored 13 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Anna Tassidou's work include Multiple Myeloma Research and Treatments (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Anna Tassidou is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Anna Tassidou collaborates with scholars based in Greece, United States and Poland. Anna Tassidou's co-authors include Efstathia K. Kapsogeorgou, Clio P. Mavragani, Mary K. Crow, Michael Voulgarelis, Michael Koutsilieris, Adrianos Nezos, Meletios Α. Dimopoulos, Efstathios Kastritis, Μαρία Ρούσσου and Evangelos Terpos and has published in prestigious journals such as Blood, Gastroenterology and Journal of Autoimmunity.

In The Last Decade

Anna Tassidou

13 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Tassidou Greece 8 199 184 115 106 105 13 482
Bineta Ly France 10 133 0.7× 75 0.4× 143 1.2× 86 0.8× 62 0.6× 15 384
Juliette Pascaud France 9 117 0.6× 89 0.5× 116 1.0× 76 0.7× 53 0.5× 25 367
T. M. Vroom Netherlands 12 159 0.8× 68 0.4× 313 2.7× 69 0.7× 102 1.0× 24 652
Liunan Li United States 8 234 1.2× 146 0.8× 324 2.8× 153 1.4× 84 0.8× 9 639
Yunyun Fei China 13 180 0.9× 105 0.6× 108 0.9× 244 2.3× 43 0.4× 48 539
Matthew T. Howard United States 12 39 0.2× 185 1.0× 79 0.7× 46 0.4× 102 1.0× 55 466
Mariko Yabe United States 14 87 0.4× 65 0.4× 113 1.0× 53 0.5× 142 1.4× 39 466
Chik Hong Kuick Singapore 14 110 0.6× 117 0.6× 30 0.3× 91 0.9× 105 1.0× 50 473
E. Christiaan Hagen Netherlands 11 135 0.7× 81 0.4× 194 1.7× 173 1.6× 17 0.2× 12 652
Marina Narbaitz Argentina 15 88 0.4× 63 0.3× 126 1.1× 46 0.4× 411 3.9× 55 663

Countries citing papers authored by Anna Tassidou

Since Specialization
Citations

This map shows the geographic impact of Anna Tassidou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Tassidou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Tassidou more than expected).

Fields of papers citing papers by Anna Tassidou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Tassidou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Tassidou. The network helps show where Anna Tassidou may publish in the future.

Co-authorship network of co-authors of Anna Tassidou

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Tassidou. A scholar is included among the top collaborators of Anna Tassidou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Tassidou. Anna Tassidou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bilalis, Antonios, et al.. (2017). Increased expression of platelet derived growth factor receptor β on trephine biopsies correlates with advanced myeloma.. PubMed. 22(4). 1032–1037. 6 indexed citations
2.
Nezos, Adrianos, Anna Tassidou, Efstathia K. Kapsogeorgou, et al.. (2015). Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis. Journal of Autoimmunity. 63. 47–58. 193 indexed citations
3.
Kapsogeorgou, Efstathia K., Maria Christodoulou, Demosthenes B. Panagiotakos, et al.. (2013). Minor Salivary Gland Inflammatory Lesions in Sjögren Syndrome: Do They Evolve?. The Journal of Rheumatology. 40(9). 1566–1571. 57 indexed citations
4.
Dimopoulos, Meletios Α., Efstathios Kastritis, Μαρία Ρούσσου, et al.. (2009). Rituximab-Based Treatments in Waldenström's Macroglobulinemia. Clinical Lymphoma & Myeloma. 9(1). 59–61. 10 indexed citations
5.
Mollaki, Vasiliki, Anna Tassidou, Μαρία Ιωάννου, et al.. (2009). Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate–gene association study. Journal of Human Genetics. 54(11). 655–659. 53 indexed citations
6.
Kastritis, Efstathios, Αchilles Anagnostopoulos, Μαρία Ρούσσου, et al.. (2007). Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone. Haematologica. 92(10). 1351–1358. 125 indexed citations
7.
Kastritis, Efstathios, Athanasios K. Anagnostopoulos, Μαρία Ρούσσου, et al.. (2007). Treatment of Light Chain (AL) Amyloidosis and Light Chain Deposition Disease (LCDD) with the Combination of Bortezomib and Dexamethasone.. Blood. 110(11). 191–191. 1 indexed citations
8.
Bozas, George, et al.. (2006). Non-Hodgkin's Lymphoma of the Renal Pelvis. Clinical Lymphoma & Myeloma. 6(5). 404–406. 5 indexed citations
9.
Bozas, George, Dimitra Anagnostou, Anna Tassidou, et al.. (2005). Extranodal non-Hodgkin's lymphoma presenting as an abdominal wall mass. A case report and review of the literature. Leukemia & lymphoma. 47(2). 329–332. 9 indexed citations
10.
Anagnostopoulos, Αchilles, Dimitra Gika, George Hamilos, et al.. (2004). Treatment of Relapsed/Refractory Multiple Myeloma with Thalidomide-based Regimens: Identification of Prognostic Factors. Leukemia & lymphoma. 45(11). 2275–2279. 10 indexed citations
11.
Christopoulos, Constantinos, et al.. (2001). Concomitant angioimmunoblastic T-cell lymphoma and low grade B-cell lymphoproliferative disorder. Clinical & Laboratory Haematology. 23(2). 139–142. 1 indexed citations
12.
Georgopoulos, Sotirios D., Κonstantinos Τriantafyllou, Panagiota Kitsanta, et al.. (2001). Molecular analysis of B-cell clonality in Helicobacter pylori gastritis. Gastroenterology. 120(5). A747–A747. 3 indexed citations
13.
Dimopoulos, Meletios Α., Panayiotis Panayiotidis, Vassiliki Grigoraki, et al.. (2001). Oral hyperfractionated cyclophosphamide and intermittent thalidomide-dexamethasone for previously treated patients with multiple myeloma. 1. 16416. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026